Terms: = Ovarian cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
2500 results:
1. Anxiety Levels in Brazilian Women with Metastatic Breast cancer Undergoing Palliative Chemotherapy: A Prospective Study.
Marcondes L; Silva LDS; Ribeiro CO; Oshiro NN; Nogueira LA; Guimaraes PRB; Kalinke LP
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1135-1141. PubMed ID: 38679972
[TBL] [Abstract] [Full Text] [Related]
2. Common misconceptions and myths about ovarian cancer causation: a national cross-sectional study from palestine.
Elshami M; Jaber I; Alser M; Al-Slaibi I; Jabr H; Ubaiat S; Tuffaha A; Khader S; Khraishi R; Arafeh ZA; Al-Madhoun S; Alqattaa A; Yaseen A; El Hadi AA; Barhoush O; Hijazy M; Eleyan T; Alser A; Hziema AA; Shatat A; Almakhtoob F; Mohamad B; Farhat W; Abuamra Y; Mousa H; Adawi R; Musallam A; Albarqi SI; Abu-El-Noor N; Bottcher B
BMC Public Health; 2024 Apr; 24(1):1027. PubMed ID: 38609950
[TBL] [Abstract] [Full Text] [Related]
3. Bayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers.
Abrego L; Zaikin A; Marino IP; Krivonosov MI; Jacobs I; Menon U; Gentry-Maharaj A; Blyuss O
Cancer Med; 2024 Apr; 13(7):e7163. PubMed ID: 38597129
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of the CARE-FCR: A caregiver-specific measure of fear of cancer recurrence and progression.
Webb K; Sharpe L; Russell H; Shaw J
Psychooncology; 2024 Apr; 33(4):e6341. PubMed ID: 38593275
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast cancer.
Leon-Ferre RA; Jonas SF; Salgado R; Loi S; de Jong V; Carter JM; Nielsen TO; Leung S; Riaz N; Chia S; Jules-Clément G; Curigliano G; Criscitiello C; Cockenpot V; Lambertini M; Suman VJ; Linderholm B; Martens JWM; van Deurzen CHM; Timmermans AM; Shimoi T; Yazaki S; Yoshida M; Kim SB; Lee HJ; Dieci MV; Bataillon G; Vincent-Salomon A; André F; Kok M; Linn SC; Goetz MP; Michiels S;
JAMA; 2024 Apr; 331(13):1135-1144. PubMed ID: 38563834
[TBL] [Abstract] [Full Text] [Related]
6. The Development and Testing of a Patient Decision Aid for Individuals with Homologous Recombinant Proficient ovarian cancer Who Are Considering Niraparib Maintenance Therapy.
Hopkins L; Carey M; Brown L; McCrea S; Milne M; Tokaryk D; Stacey D
Curr Oncol; 2024 Mar; 31(3):1416-1425. PubMed ID: 38534940
[TBL] [Abstract] [Full Text] [Related]
7. PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
Güzel D; Terek C; Besler A; Serin G; Önal Z; Akman L; Göker E; Ali Şanli U; Zekioğlu O; Özdemir N; Özsaran A; Yildirim N
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():321-326. PubMed ID: 38518487
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological features and surgical procedures of adnexal masses with abdominal pain in pediatric and adolescent patients.
Liu Q; Li Z; Zhou H; Cao D; Yang J; Shen K; Lang J
Orphanet J Rare Dis; 2024 Mar; 19(1):132. PubMed ID: 38515195
[TBL] [Abstract] [Full Text] [Related]
9. Diagnosis Shift in Site of Origin of Tubo-ovarian Carcinoma.
Lee MW; Anderson ZS; Girma AM; Klar M; Roman LD; Carlson JW; Wright JD; Sood AK; Matsuo K
Obstet Gynecol; 2024 May; 143(5):660-669. PubMed ID: 38513238
[TBL] [Abstract] [Full Text] [Related]
10. Enhancing precision medicine: a nomogram for predicting platinum resistance in epithelial ovarian cancer.
Li R; Xiong Z; Ma Y; Li Y; Yang Y; Ma S; Ha C
World J Surg Oncol; 2024 Mar; 22(1):81. PubMed ID: 38509620
[TBL] [Abstract] [Full Text] [Related]
11. CRISPR du-HITI an attractive approach to targeting Long Noncoding RNA HCP5 as inhibitory factor for proliferation of ovarian cancer cell.
Moradi Z; Kazemi M; Jamshidi-Khalifelou R; Bahramnia V; Esfandmaz F; Rahnavard R; Moradgholi B; Piri-Gharaghie T
Funct Integr Genomics; 2024 Mar; 24(2):61. PubMed ID: 38507114
[TBL] [Abstract] [Full Text] [Related]
12. Small-molecule inhibitor HI-TOPK-032 improves NK-92MI cell infiltration into ovarian tumours.
Deng M; Yang R; Sun Q; Zhang J; Miao J
Basic Clin Pharmacol Toxicol; 2024 May; 134(5):629-642. PubMed ID: 38501576
[TBL] [Abstract] [Full Text] [Related]
13. Body mass index and risk of cancer in young women.
Dikaiou P; Edqvist J; Lagergren J; Adiels M; Björck L; Rosengren A
Sci Rep; 2024 Mar; 14(1):6245. PubMed ID: 38485791
[TBL] [Abstract] [Full Text] [Related]
14. Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer.
Boidot R; Blum MGB; Wissler MP; Gottin C; Ruzicka J; Chevrier S; Delhomme TM; Audoux J; Jeanniard A; Just PA; Harter P; Pignata S; González-Martin A; Marth C; Mäenpää J; Colombo N; Vergote I; Fujiwara K; Duforet-Frebourg N; Bertrand D; Philippe N; Ray-Coquard I; Pujade-Lauraine E;
Eur J Cancer; 2024 May; 202():113978. PubMed ID: 38471290
[TBL] [Abstract] [Full Text] [Related]
15. A clinicopathological study about the epidemiology of granulosa cell tumors in Lebanon.
Yaacoub S; Hajj L; Khairallah A
BMC Cancer; 2024 Mar; 24(1):309. PubMed ID: 38448917
[TBL] [Abstract] [Full Text] [Related]
16. cancer Risks Associated With
Fortuno C; Feng BJ; Carroll C; Innella G; Kohlmann W; Lázaro C; Brunet J; Feliubadaló L; Iglesias S; Menéndez M; Teulé A; Ballinger ML; Thomas DM; Campbell A; Field M; Harris M; Kirk J; Pachter N; Poplawski N; Susman R; Tucker K; Wallis M; Williams R; Cops E; Goldgar D; ; James PA; Spurdle AB
JCO Precis Oncol; 2024 Feb; 8():e2300453. PubMed ID: 38412388
[TBL] [Abstract] [Full Text] [Related]
17. An integrated machine learning-based model for joint diagnosis of ovarian cancer with multiple test indicators.
Feng Y
J Ovarian Res; 2024 Feb; 17(1):45. PubMed ID: 38378582
[TBL] [Abstract] [Full Text] [Related]
18. Low-dose aspirin use and risk of ovarian cancer: a combined analysis from two nationwide studies in Denmark and Sweden.
Zheng G; Faber MT; Wang J; Baandrup L; Hertzum-Larsen R; Sundström K; Kjær SK
Br J Cancer; 2024 May; 130(8):1279-1285. PubMed ID: 38347096
[TBL] [Abstract] [Full Text] [Related]
19. Maternal and perinatal risks for monozygotic twins conceived following frozen-thawed embryo transfer: a retrospective cohort study.
Lin J; Zhang K; Wu F; Wang B; Chai W; Zhu Q; Huang J; Lin J
J Ovarian Res; 2024 Feb; 17(1):36. PubMed ID: 38326864
[TBL] [Abstract] [Full Text] [Related]
20. Platinum desensitization therapy and its impact on the prognosis of ovary high-grade serous adenocarcinoma: a real world-data.
Li K; Yin R
Front Immunol; 2024; 15():1346464. PubMed ID: 38312839
[TBL] [Abstract] [Full Text] [Related]
[Next]
